Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

brain-1845962_960_720

New study challenges link between stress and migraines

January 25, 2021 Sales and Marketing Curelator, migraine

Digital health platform Curelator has announced new data that shows a lack of association between increased stress and migraine attacks. …
News
genentech_web

Genentech announces positive top-line results for “wet” age-related macular degeneration antibody

January 25, 2021 Sales and Marketing Genentech

Genentech has announced positive top-line results from two identically designed global Phase III studies, TENAYA and LUCERNE, evaluating its investigational …
News
mr058666-web

Merck KGaA’s cancer drug Bavencio gets EU approval

January 25, 2021 Sales and Marketing Merck KGaA

The EC has approved Merck KGaA’s BAVENCIO (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with locally …
News
nicki_grundy

Raremark appoints Nicki Grundy as CFO

January 20, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer. As a key …
Appointment
jubilant

Jubilant and The Wistar Insitute collaborate on potential COVID-19 treatment

January 18, 2021 Sales and Marketing Jubilant Therapeutics

Jubilant Therapeutics, a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, has …
News
senior-woman-suffering-from-knee-pain-home_61573-2004

Theramex launches osteoporosis drug Livogiva in Europe

January 18, 2021 Sales and Marketing Theramex, osteoporosis

Theramex, a London-headquartered pharmaceutical company dedicated to women’s health, has launched osteoporosis medicine Livogiva to patients in Europe for the …
News
viiv

ViiV and Chelsea & Westminster Hospital launch digital service for HIV patients

January 18, 2021 Sales and Marketing HIV, ViiV Healthcare

Global specialist HIV company ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust have launched a new service, Klick, …
News
pentagon-headquarters-us-department-of-defense-virginia

US Department of Defense selects Faron for $6.1m COVID-19 research funding

January 18, 2021 Sales and Marketing Faron Pharmaceuticals, US

The US Department of Defense (DoD) has selected Faron Pharmaceuticals’ HIBISCUS study to receive $6.1 million of funding from the …
News
janssen_latest_logo_on_sign

FDA approves Janssen’s AL amyloidosis drug

January 18, 2021 Sales and Marketing FDA, Janssen

The FDA has approved Janssen’s DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone …
News
richard_francis

Purespring Therapeutics to appoint Richard Francis as CEO

January 11, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from …
Appointment
lilly_building_with_american_flag_web

Eli Lilly’s Alzheimer’s drug slows clinical decline in Phase II trial

January 11, 2021 Sales and Marketing Alzheimer's, Eli Lilly

Eli Lilly’s donanemab has shown significant slowing of decline in a composite measure of cognition and daily function in patients …
News
roche_dark_0

Roche’s influenza drug Xofluza gets EU approval

January 11, 2021 Sales and Marketing EC, Roche, influenza

The European Commission (EC) has approved Roche’s Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 …
News

MaxCyte signs licensing deal with Myeloid Therapeutics

January 11, 2021 Sales and Marketing MaxCyte, Myeloid Therapeutics

MaxCyte, a global cell-based therapies and life sciences company, and Myeloid Therapeutics, a company harnessing and reprogramming myeloid cells to …
News

Sanofi to acquire Kymab for $1.1bn

January 11, 2021 Sales and Marketing Malin, Sanofi, kymab

Sanofi is to acquire clinical-stage biopharmaceutical company Kymab for approximately $1.1 billion. In addition to this upfront sum, Paris-headquartered Sanofi …
News
vaccination

Seven mass vaccination sites open in England

January 11, 2021 Sales and Marketing COVID-19, UK, Vaccine

Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026